Devices & Diagnostics
-
MedCity Influencers, Devices & Diagnostics
How Medicare Coverage Diversifies Access to Innovation
Appropriate Medicare reimbursement of high-intensity focused ultrasound for prostate disease is a significant development for the treatment for men 65 years and older today.
-
MedCity Influencers, Devices & Diagnostics
Accelerating the Move to Precision Oncology
By continuing an open discussion on precision medicine and precision care, we can truly accelerate pharmacogenomic testing to its full potential and focus on providing the highest quality care to those who need it most.
-
The Challenges of Temperature Controlled Logistics and How to Overcome Them
MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.
-
Health Tech Startups Should Consider Adding Data to Their Marketing & PR Strategy
Creating a successful primary data marketing campaign relies on asking the right questions, keeping the end user in mind, proper analysis and a long-term plan for its use.
-
Why Digital Marketing for Healthcare Needs To Redefine the Traditional ‘Blueprint’ Strategy
Healthcare brands should always build their own digital marketing strategy from scratch – rather than using a blueprint from another successful digital industry.
-
INVEST Pitch Perfect Spotlight: How Prana Thoracic Can Help Treat Lung Cancer Sooner
Prana Thoracic, a startup focused on earlier detection and intervention for lung cancer, recently won the medical devices track of the MedCity News INVEST Pitch Perfect contest. The company is developing a minimally invasive electrosurgical device to help thoracic surgeons better excise smaller and intermediate-size lung nodules.
-
Ezra Earns FDA Clearance for AI Tool that Makes MRIs Faster & Cheaper
New York-based startup Ezra recently received FDA clearance for an AI tool it plans to use to launch “the world’s first 30-minute full body MRI scan.” The tool, named Ezra Flash, enhances the quality of MR images so that radiologists can detect cancer earlier.
-
Canadian Showcase at MedCity INVEST Champions Healthcare Innovation
Presented by the Consulate General of Canada, the Canadian healthcare startup showcase included five companies. Technologies included a patient transfer solution, care coordination, women’s health, exercise tracking and remote monitoring for dysphagia, and mental health support.
-
Which Healthcare Startups Won the MedCity INVEST Pitch Perfect Contest?
The competition saw 23 healthcare startups across biopharma, medical devices, and health tech geared for consumers/employers as well as payers/providers pitch their business plans to teams of investor judges.
-
TriNet Pharma Highlights the Rise of the Medical Science Liaison and Honors Legacy of Its Founder
As pharmaceutical reps are used less and less, the role of the MSL has become more prominent as a conduit between life sciences companies and external stakeholders for drug development.
-
Creating an Omnichannel Customer Journey in Healthcare
Improving Customer Experience and Conversion in Healthcare & Life Sciences
-
MedCity INVEST Ask the Investor Spotlight: Yaniv Sneor of Mid Atlantic Bio Angels
Yaniv Sneor, the co-founder of Mid Atlantic Bio Angels and part of the Ask the Investor sessions at MedCity INVEST this week, explained what his firm looks for in life science startups.
-
Devices & Diagnostics, Startups
Moon Surgical Snags $55.5M for Its Robotic Laparoscopy Assistant
Moon Surgical recently raised $55.5 million for its robotic surgical assistant, which has earned regulatory clearance in the U.S. and European Union. The startup also appointed Fred Moll, founder of Intuitive Surgical and Auris Health, as independent chair of its board.
-
Access and Diversity in Clinical Trials Requires Supporting the Investigators
When we bring physicians from underserved communities into research through a reimagined model, we can impact better health outcomes rooted in quality data that allows us to thrive from more diversity and better representation while providing patients with greater access to new care options.
-
FDA’s Landmark Guidance on Decentralized Clinical Trials (DCTs) Signals a New Era of Patient-Centered Research
With the FDA’s acceptance and encouragement of decentralized trials, we can expect to see a continued shift towards remote trial conduct, virtual sites, and the use of innovative digital technologies.
-
Without Change, Lifesaving HCT and Cell Therapies Will Be Out of Reach for Many
Ending access and outcomes disparities in HCT and cell therapy will require a collaborative effort, from clinicians, associations and non-profit organizations in the hematology/oncology, HCT and cell therapy communities to policy makers and payers
-
MedCity Influencers, Devices & Diagnostics, Artificial Intelligence
AI Can Make Precision Medicine More Accessible to Patients Who Might Not Have Been Able to Benefit in the Past
“Precision medicine” is a term we have heard a lot over the last two decades, […]
Promoted
Healthcare VC Jumpstart Foundry Now Accepting Applications for Fall Funding
Early-stage healthcare innovation fund Jumpstart Foundry is accepting Fall funding applications through September 30th. Read on to find out why Jumpstart Foundry could be the missing piece in your startup’s journey to making a lasting difference in healthcare.
